Dendrimer‐Based Macromolecular Conjugate for the Kidney‐Directed Delivery of a Multitargeted Sunitinib Analogue
M. Emmy M. Dolman(Cancer Institute of New South Wales), Robbert J. Kok(Utrecht University), Niels Bovenschen(Utrecht University), Bálint Szokol(Vichem Chemie (Hungary)), Kim M. A. van Dorenmalen(Utrecht University), Rolf W. Sparidans(Slotervaartziekenhuis), M. Lacombe(Université du Québec à Rimouski), László Őrfi, Gÿorgý Kéri(Semmelweis University), Gert Storm(Yong In University), Ebel H. E. Pieters(Utrecht University), Wim E. Hennink(Utrecht University)
Cited by 22
Related Papers
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396